跳至主要内容
临床试验/NCT00091351
NCT00091351已完成3 期

A Phase III Randomized Study of Preoperative Radiation Plus Surgery Versus Surgery Alone for Patients With Retroperitoneal Sarcomas (RPS)

Alliance for Clinical Trials in Oncology118 个研究点 分布在 1 个国家目标入组 370 人开始时间: 2004年8月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
370
试验地点
118
主要终点
Progression-free survival at 5 years

研究概览

简要总结

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy before surgery may shrink the tumor so that it can be removed. It is not yet known whether surgery is more effective with or without radiation therapy.

PURPOSE: This randomized phase III trial is studying surgery alone to see how well it works compared to radiation therapy together with surgery in treating patients with primary soft tissue sarcoma of the retroperitoneum or pelvis.

详细描述

OBJECTIVES:

Primary

  • Compare progression-free survival of patients with primary soft tissue sarcoma of the retroperitoneum or pelvis treated with surgery with vs without preoperative radiotherapy.

Secondary

  • Compare the toxicity and complications associated with these regimens in these patients.
  • Compare the rate of microscopically complete surgical resection in patients treated with these regimens.
  • Compare the overall survival rate of patients treated with these regimens.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Progression-free survival at 5 years

时间窗: at 5 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (118)

Loading locations...

相似试验